State of the art tissue engineering

Body-own tissue, no rejection

Grown at location where needed

Through an implantable Medical Device

True platform technology

Strong IP protection

Clinical success

Clinical primary and secondary objectives met

Safe – no safety issues

Effective – no deviations from performance claims

Consistent with results from four animal models

Commercial launch

First applications in cardiovascular

Initial focus on unmet need in hemodialysis

Quality Management System

CuroTis’ Quality Management System is audited and certified by Dekra

Certified by the European Union